Big update from Rescue Hearing Inc. 🚀 We’re thrilled to announce our latest news: “MED-EL Acquires Two Gene Therapy Programs Targeting Genetic Causes of Balance and Hearing Disorders“. Get the full story here 👇 #Rescue Hearing Inc.

Today, we want to thank the incredible community that has been part of Rescue Hearing's journey. We're proud to share that MED-EL has acquired Rescue Hearing's MYO7A and STRC gene therapy programs, marking an important milestone in years of research focused on genetic hearing and balance disorders. This achievement reflects the dedication of researchers, clinicians, families, volunteers, advocates, and supporters who believed in our mission from the very beginning. While research continues and there is still important work ahead, this milestone represents meaningful progress in advancing research that may one day benefit families affected by genetic hearing and balance disorders. To everyone who has supported Rescue Hearing over the years, thank you. This milestone belongs to all of you. Read the full announcement:https://rescuehearing.com/press-releases/med-el-acquires-two-gene-therapy-programs-targeting-genetic-causes-of-balance-and-hearing-disorders/

We're pleased to share an important milestone in Rescue Hearing's mission to advance research into genetic hearing and balance disorders. MED-EL has acquired full rights to Rescue Hearing's MYO7A and STRC gene therapy programs, expanding its research activities into gene-based therapeutic approaches that complement its existing portfolio of hearing solutions. This announcement reflects years of scientific research, collaboration, and dedication by researchers, clinicians, advisors, supporters, and families who believe in advancing new possibilities for people affected by genetic hearing and balance disorders. We believe MED-EL's global research, engineering, and clinical expertise provide a strong foundation for advancing these programs through their next phase of development. While significant work remains, this milestone represents meaningful progress in the continued advancement of research for genetic hearing and balance disorders. Read the full announcement: https://rescuehearing.com/press-releases/med-el-acquires-two-gene-therapy-programs-targeting-genetic-causes-of-balance-and-hearing-disorders/ #GeneTherapy #Biotechnology #GeneticHearingLoss #HearingResearch #RareDisease #LifeSciences #MedicalInnovation #RescueHearing

Rescue Hearing Inc. is excited to share our latest milestone, and we’re proud of the teams and partners who helped make this happen! 🎉 “MED-EL Acquires Two Gene Therapy Programs Targeting Genetic Causes of Balance and Hearing Disorders” Check out the announcement and join the conversation: #Rescue Hearing Inc.

We're pleased to share an important announcement from Rescue Hearing. MED-EL has acquired Rescue Hearing's MYO7A and STRC gene therapy programs, expanding its research activities into gene-based therapeutic approaches for genetic hearing and balance disorders. This milestone reflects years of scientific research, collaboration, and dedication to advancing the understanding of genetic hearing and balance disorders. We believe MED-EL's global research, engineering, manufacturing, and clinical expertise provide a strong foundation for advancing these programs through their next phase of development. We look forward to supporting the continued advancement of research that may benefit people affected by genetic hearing and balance disorders. Read the full announcement: https://rescuehearing.com/press-releases/med-el-acquires-two-gene-therapy-programs-targeting-genetic-causes-of-balance-and-hearing-disorders/ #GeneTherapy #GeneticHearingLoss #HearingResearch #RareDisease #Biotechnology #MedicalInnovation #PrecisionMedicine #RescueHearing

We're pleased to share an important milestone in Rescue Hearing's mission to advance research into genetic hearing and balance disorders. MED-EL has acquired full rights to Rescue Hearing's MYO7A and STRC gene therapy programs, expanding its research activities into gene-based therapeutic approaches that complement its existing portfolio of hearing solutions. This announcement reflects years of scientific research, collaboration, and dedication by researchers, clinicians, advisors, supporters, and families who believe in advancing new possibilities for people affected by genetic hearing and balance disorders. We believe MED-EL's global research, engineering, and clinical expertise provide a strong foundation for advancing these programs through their next phase of development. While significant work remains, this milestone represents meaningful progress in the continued advancement of research for genetic hearing and balance disorders. Read the full announcement: https://rescuehearing.com/press-releases/med-el-acquires-two-gene-therapy-programs-targeting-genetic-causes-of-balance-and-hearing-disorders/ #GeneTherapy #Biotechnology #GeneticHearingLoss #HearingResearch #RareDisease #LifeSciences #MedicalInnovation #RescueHearing

Today, we want to thank the incredible community that has been part of Rescue Hearing's journey. We're proud to share that MED-EL has acquired Rescue Hearing's MYO7A and STRC gene therapy programs, marking an important milestone in years of research focused on genetic hearing and balance disorders. This achievement reflects the dedication of researchers, clinicians, families, volunteers, advocates, and supporters who believed in our mission from the very beginning. While research continues and there is still important work ahead, this milestone represents meaningful progress in advancing research that may one day benefit families affected by genetic hearing and balance disorders. To everyone who has supported Rescue Hearing over the years, thank you. This milestone belongs to all of you. Read the full announcement:https://rescuehearing.com/press-releases/med-el-acquires-two-gene-therapy-programs-targeting-genetic-causes-of-balance-and-hearing-disorders/

We're pleased to share an important announcement from Rescue Hearing. MED-EL has acquired Rescue Hearing's MYO7A and STRC gene therapy programs, expanding its research activities into gene-based therapeutic approaches for genetic hearing and balance disorders. This milestone reflects years of scientific research, collaboration, and dedication to advancing the understanding of genetic hearing and balance disorders. We believe MED-EL's global research, engineering, manufacturing, and clinical expertise provide a strong foundation for advancing these programs through their next phase of development. We look forward to supporting the continued advancement of research that may benefit people affected by genetic hearing and balance disorders. Read the full announcement: https://rescuehearing.com/press-releases/med-el-acquires-two-gene-therapy-programs-targeting-genetic-causes-of-balance-and-hearing-disorders/ #GeneTherapy #GeneticHearingLoss #HearingResearch #RareDisease #Biotechnology #MedicalInnovation #PrecisionMedicine #RescueHearing